Translational medicine, which bridges scientific discovery to clinical experimentation for the development of novel pharmaceutical products, emerges as a critical step in the path to successful therapeutic innovation for biopharmaceutical companies.  The mouse is pivotal, as a model organism, in the translational medicine path, to turn genomic data and information that are accumulating with increasing speed, into critical knowledge to:  identify and validate specific therapeutic targets, understand disease mechanisms, identify drug candidates, potential alternative or additional indications, validate selected intended indications of candidate drugs, identify the side effects of candidate drugs


genOway and PhenoPro create the most advanced and innovative offer in animal model creation and phenotyping. genOway will exclusively offer to the scientific community a complete range of services from creation to phenotyping of genetically modified mouse models by integrating PhenoPro unrivalled phenotyping services.

See the whole news.


Phenopro was present :

  • at the 2013 BIO international Convention April 22-25th, in Chicago. The BIO international Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry. The Convention also features the BIO business Forum (One-on-One Partnering), hundreds of sessions covering biotech trends, policy issues and technological innovations, and the world’s largest biotechnology exhibition-The BIO Exhibition.
  • at the French Biotech Tour 2012, IMMUNOLOGY, INFLAMMATION and NEUROLOGY, October 16th, in San Francisco. The FRENCH BIOTECH TOURS aim to provide industry professionals with essential contacts and strategic partnership opportunities in a specific therapeutic field. Former participants include large pharmaceutical laboratories (Abbott, Amgen, AstraZeneca, Eli Lilly, Johnson & Johnson, Novartis, Sanofi Pasteur, Sanofi, Merck, Pfizer, etc.), 140 American biotech companies and 70 French companies.
  • at the 2012 BIO International Convention June 18-21st, in Boston.
  • at the Informa Life Sciences' 5th Annual Animal Models for Therapeutic Research 2012 Conference in Berlin.